EPF's EU Elections campaign 2024
Towards a truly participatory, democratic, and impactful involvement of patient organisations
Towards a truly participatory, democratic, and impactful involvement of patient organisations
Patient safety transcends every aspect of healthcare and health policy-making, from the organisation of healthcare systems to addressing emerging threats like antimicrobial resistance that impact patients’ access to safe care.
From 12 January 2025, the new EU regulation on Health Technology Assessment (HTAR) will significantly shift how health technologies are evaluated across Europe. This regulation introduces a more structured and standardised approach to HTA,
On 10 April 2024, the European Parliament adopted the reports on the Directive and the Regulation, thus formalising the Parliament's official position on the revision of the EU pharmaceutical legislation. The reports of the European Parliament
As your advocate, EPF provides many benefits to its members. We represent our members' voice at the European level on cross-cutting health issues.